Cholate Clearance in Fontan and Heart Failure

RecruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

August 4, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2031

Conditions
FontanRight Heart Failure
Interventions
DEVICE

Dual cholate clearance assay

Study participants are administered labeled oral and intravenous cholate, and then two blood samples are taken over 60-minutes. Serum cholate levels are measured by blood draws.

RADIATION

MRI

Unsedated non contrast cardiac magnetic resonance imaging (MRI)

Trial Locations (1)

19104

RECRUITING

Hospital of the University of Pennsylvania, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

lead

HepQuant, LLC

INDUSTRY

NCT07009132 - Cholate Clearance in Fontan and Heart Failure | Biotech Hunter | Biotech Hunter